Clinical trial
Combined Chemotherapy With or Without Zoledronic Acid for Patients With…
NCT00470223 · UNICANCER, Other · Active, not recruiting
Key facts
| NCT number | NCT00470223 |
|---|---|
| Title | Combined Chemotherapy With or Without Zoledronic Acid for Patients With Osteosarcoma |
| Official title | OS2006 : Protocole de Traitement Des ostéosarcomes de l'Enfant, de l'Adolescent et de l'Adulte Comportant |
| Acronym | OS2006 |
| Lead sponsor | UNICANCER, Other |
| Collaborators | Novartis Industry Chugai Pharmaceutical National Cancer Institute, France SFCE Ligue contre le cancer, France |
| Status | Active, not recruiting |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Sarcoma |
| Intervention type | Drug, Procedure |
| Interventions | cisplatin, doxorubicin hydrochloride, etoposide, ifosfamide, methotrexate, zoledronic acid, conventional surgery |
| Enrollment | 318 |
| Start date | Mar 1, 2007 |
| Primary completion | Dec 1, 2015 |
| Completion | Dec 1, 2026 |
| First posted | May 7, 2007 |
| Last update posted | Jun 8, 2025 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: